Global Oral Hypoglycemic Agents (OHAs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 121
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Oral Hypoglycemic Agents (OHAs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Oral Hypoglycemic Agents (OHAs) industry chain, the market status of Type 2 Diabetes Mellitus (Sulfonylureas, Metformin), Type 1 Diabetes Mellitus (Sulfonylureas, Metformin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Hypoglycemic Agents (OHAs).
Regionally, the report analyzes the Oral Hypoglycemic Agents (OHAs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Hypoglycemic Agents (OHAs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Hypoglycemic Agents (OHAs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Hypoglycemic Agents (OHAs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Sulfonylureas, Metformin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Hypoglycemic Agents (OHAs) market.
Regional Analysis: The report involves examining the Oral Hypoglycemic Agents (OHAs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Hypoglycemic Agents (OHAs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Hypoglycemic Agents (OHAs):
Company Analysis: Report covers individual Oral Hypoglycemic Agents (OHAs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Hypoglycemic Agents (OHAs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus).
Technology Analysis: Report covers specific technologies relevant to Oral Hypoglycemic Agents (OHAs). It assesses the current state, advancements, and potential future developments in Oral Hypoglycemic Agents (OHAs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Hypoglycemic Agents (OHAs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Hypoglycemic Agents (OHAs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Sulfonylureas
Metformin
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Market segment by Application
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Major players covered
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Hypoglycemic Agents (OHAs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Hypoglycemic Agents (OHAs), with price, sales, revenue and global market share of Oral Hypoglycemic Agents (OHAs) from 2019 to 2024.
Chapter 3, the Oral Hypoglycemic Agents (OHAs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Hypoglycemic Agents (OHAs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Hypoglycemic Agents (OHAs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Hypoglycemic Agents (OHAs).
Chapter 14 and 15, to describe Oral Hypoglycemic Agents (OHAs) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oral Hypoglycemic Agents (OHAs)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Sulfonylureas
1.3.3 Metformin
1.3.4 Thiazolidinediones
1.3.5 Alpha-Glucosidase Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Type 2 Diabetes Mellitus
1.4.3 Type 1 Diabetes Mellitus
1.5 Global Oral Hypoglycemic Agents (OHAs) Market Size & Forecast
1.5.1 Global Oral Hypoglycemic Agents (OHAs) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Hypoglycemic Agents (OHAs) Sales Quantity (2019-2030)
1.5.3 Global Oral Hypoglycemic Agents (OHAs) Average Price (2019-2030)
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
2.1.4 Pfizer Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
2.2.4 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
2.3.4 Bayer Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
2.4.4 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Novonordisk
2.5.1 Novonordisk Details
2.5.2 Novonordisk Major Business
2.5.3 Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
2.5.4 Novonordisk Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novonordisk Recent Developments/Updates
2.6 Sanofi-Aventis
2.6.1 Sanofi-Aventis Details
2.6.2 Sanofi-Aventis Major Business
2.6.3 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
2.6.4 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi-Aventis Recent Developments/Updates
2.7 Servier
2.7.1 Servier Details
2.7.2 Servier Major Business
2.7.3 Servier Oral Hypoglycemic Agents (OHAs) Product and Services
2.7.4 Servier Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Servier Recent Developments/Updates
2.8 Huadong Medicine
2.8.1 Huadong Medicine Details
2.8.2 Huadong Medicine Major Business
2.8.3 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
2.8.4 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Huadong Medicine Recent Developments/Updates
2.9 Wanbang Biopharmaceuticals
2.9.1 Wanbang Biopharmaceuticals Details
2.9.2 Wanbang Biopharmaceuticals Major Business
2.9.3 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
2.9.4 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
2.10 Double-Crane Pharmaceutical
2.10.1 Double-Crane Pharmaceutical Details
2.10.2 Double-Crane Pharmaceutical Major Business
2.10.3 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
2.10.4 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Double-Crane Pharmaceutical Recent Developments/Updates
2.11 Guangzhou Pharmaceutical
2.11.1 Guangzhou Pharmaceutical Details
2.11.2 Guangzhou Pharmaceutical Major Business
2.11.3 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
2.11.4 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Guangzhou Pharmaceutical Recent Developments/Updates
3.1 Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturer (2019-2024)
3.3 Global Oral Hypoglycemic Agents (OHAs) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oral Hypoglycemic Agents (OHAs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oral Hypoglycemic Agents (OHAs) Manufacturer Market Share in 2023
3.4.2 Top 6 Oral Hypoglycemic Agents (OHAs) Manufacturer Market Share in 2023
3.5 Oral Hypoglycemic Agents (OHAs) Market: Overall Company Footprint Analysis
3.5.1 Oral Hypoglycemic Agents (OHAs) Market: Region Footprint
3.5.2 Oral Hypoglycemic Agents (OHAs) Market: Company Product Type Footprint
3.5.3 Oral Hypoglycemic Agents (OHAs) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oral Hypoglycemic Agents (OHAs) Market Size by Region
4.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2019-2030)
4.1.3 Global Oral Hypoglycemic Agents (OHAs) Average Price by Region (2019-2030)
4.2 North America Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030)
4.3 Europe Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030)
4.5 South America Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030)
5.1 Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
5.2 Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type (2019-2030)
5.3 Global Oral Hypoglycemic Agents (OHAs) Average Price by Type (2019-2030)
6.1 Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
6.2 Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application (2019-2030)
6.3 Global Oral Hypoglycemic Agents (OHAs) Average Price by Application (2019-2030)
7.1 North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
7.2 North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
7.3 North America Oral Hypoglycemic Agents (OHAs) Market Size by Country
7.3.1 North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
8.2 Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
8.3 Europe Oral Hypoglycemic Agents (OHAs) Market Size by Country
8.3.1 Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Market Size by Region
9.3.1 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
10.2 South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
10.3 South America Oral Hypoglycemic Agents (OHAs) Market Size by Country
10.3.1 South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Market Size by Country
11.3.1 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Oral Hypoglycemic Agents (OHAs) Market Drivers
12.2 Oral Hypoglycemic Agents (OHAs) Market Restraints
12.3 Oral Hypoglycemic Agents (OHAs) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Oral Hypoglycemic Agents (OHAs) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Hypoglycemic Agents (OHAs)
13.3 Oral Hypoglycemic Agents (OHAs) Production Process
13.4 Oral Hypoglycemic Agents (OHAs) Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Hypoglycemic Agents (OHAs) Typical Distributors
14.3 Oral Hypoglycemic Agents (OHAs) Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
Table 6. Pfizer Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
Table 11. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
Table 16. Bayer Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
Table 21. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bristol-Myers Squibb Recent Developments/Updates
Table 23. Novonordisk Basic Information, Manufacturing Base and Competitors
Table 24. Novonordisk Major Business
Table 25. Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
Table 26. Novonordisk Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Novonordisk Recent Developments/Updates
Table 28. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi-Aventis Major Business
Table 30. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
Table 31. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sanofi-Aventis Recent Developments/Updates
Table 33. Servier Basic Information, Manufacturing Base and Competitors
Table 34. Servier Major Business
Table 35. Servier Oral Hypoglycemic Agents (OHAs) Product and Services
Table 36. Servier Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Servier Recent Developments/Updates
Table 38. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 39. Huadong Medicine Major Business
Table 40. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
Table 41. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Huadong Medicine Recent Developments/Updates
Table 43. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Wanbang Biopharmaceuticals Major Business
Table 45. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
Table 46. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 48. Double-Crane Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Double-Crane Pharmaceutical Major Business
Table 50. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
Table 51. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Double-Crane Pharmaceutical Recent Developments/Updates
Table 53. Guangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Guangzhou Pharmaceutical Major Business
Table 55. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
Table 56. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Guangzhou Pharmaceutical Recent Developments/Updates
Table 58. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Oral Hypoglycemic Agents (OHAs) Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 61. Market Position of Manufacturers in Oral Hypoglycemic Agents (OHAs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Oral Hypoglycemic Agents (OHAs) Production Site of Key Manufacturer
Table 63. Oral Hypoglycemic Agents (OHAs) Market: Company Product Type Footprint
Table 64. Oral Hypoglycemic Agents (OHAs) Market: Company Product Application Footprint
Table 65. Oral Hypoglycemic Agents (OHAs) New Market Entrants and Barriers to Market Entry
Table 66. Oral Hypoglycemic Agents (OHAs) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Oral Hypoglycemic Agents (OHAs) Average Price by Region (2019-2024) & (USD/Unit)
Table 72. Global Oral Hypoglycemic Agents (OHAs) Average Price by Region (2025-2030) & (USD/Unit)
Table 73. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Oral Hypoglycemic Agents (OHAs) Average Price by Type (2019-2024) & (USD/Unit)
Table 78. Global Oral Hypoglycemic Agents (OHAs) Average Price by Type (2025-2030) & (USD/Unit)
Table 79. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Oral Hypoglycemic Agents (OHAs) Average Price by Application (2019-2024) & (USD/Unit)
Table 84. Global Oral Hypoglycemic Agents (OHAs) Average Price by Application (2025-2030) & (USD/Unit)
Table 85. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Oral Hypoglycemic Agents (OHAs) Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Oral Hypoglycemic Agents (OHAs) Raw Material
Table 126. Key Manufacturers of Oral Hypoglycemic Agents (OHAs) Raw Materials
Table 127. Oral Hypoglycemic Agents (OHAs) Typical Distributors
Table 128. Oral Hypoglycemic Agents (OHAs) Typical Customers
List of Figures
Figure 1. Oral Hypoglycemic Agents (OHAs) Picture
Figure 2. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Type in 2023
Figure 4. Sulfonylureas Examples
Figure 5. Metformin Examples
Figure 6. Thiazolidinediones Examples
Figure 7. Alpha-Glucosidase Inhibitors Examples
Figure 8. Global Oral Hypoglycemic Agents (OHAs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Application in 2023
Figure 10. Type 2 Diabetes Mellitus Examples
Figure 11. Type 1 Diabetes Mellitus Examples
Figure 12. Global Oral Hypoglycemic Agents (OHAs) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Oral Hypoglycemic Agents (OHAs) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Oral Hypoglycemic Agents (OHAs) Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Oral Hypoglycemic Agents (OHAs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Oral Hypoglycemic Agents (OHAs) Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Oral Hypoglycemic Agents (OHAs) Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Oral Hypoglycemic Agents (OHAs) Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Oral Hypoglycemic Agents (OHAs) Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Region (2019-2030)
Figure 54. China Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Oral Hypoglycemic Agents (OHAs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Oral Hypoglycemic Agents (OHAs) Market Drivers
Figure 75. Oral Hypoglycemic Agents (OHAs) Market Restraints
Figure 76. Oral Hypoglycemic Agents (OHAs) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oral Hypoglycemic Agents (OHAs) in 2023
Figure 79. Manufacturing Process Analysis of Oral Hypoglycemic Agents (OHAs)
Figure 80. Oral Hypoglycemic Agents (OHAs) Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer GlaxoSmithKline Bayer Bristol-Myers Squibb Novonordisk Sanofi-Aventis Servier Huadong Medicine Wanbang Biopharmaceuticals Double-Crane Pharmaceutical Guangzhou Pharmaceutical
Related Reports
07 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
